Edaravone | Interleukin Related interleukin-related.com

Product Name :
Edaravone

Search keywords :
MCI

drugId :
null

Target Vo:
Free radicals

Target Vo Short Name :
Free radicals

Moa_Name:
Free radicals scavengers

First Approval Country :
Japan

First Approval Date Filter:
2001

Origin Company_Name :
Mitsubishi Tanabe Pharma Corp

Active Company_Name :
Auzone Biological Technology Pty Ltd

Active Indication_Name:
Amyotrophic Lateral Sclerosis

In Active Indication_Name:
Hepatic Insufficiency

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CCR2 Antibody
ERK5 Antibody
Rab5 Antibody: Rab5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 24 kDa, targeting to Rab5. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts